Abstract Primary synovial osteochondromatosis (PSOC) is a rare but clinically significant cause of morbidity especially in the male population. Surgery is the primary treatment of choice, but the recurrence rate is reported to be high. Moreover, the presence of widespread loose bodies makes it a cumbersome procedure. The complete removal of the disease is tough at times and results in early recurrence.
Introduction
Synovial chondromatosis is a rare benign pathology characterized by the formation of multiple cartilaginous nodules or osseous bodies in the involved joints and less commonly in the tendon sheaths or bursae. Though synovial chondromatosis can be secondary to underlying arthritis or degenerative joint disease, it often occurs in an otherwise normal joint, described as PSOC. First described in 1833 by Leanacc, it is a rare disease entity with an incidence of only 1:100,000 [1] . The disease has a male predominance and usually affects young men in the 3rd-5th decades. It is often monoarticular involving the knee in the majority of cases (∼50%) followed by the hip, elbow and the shoulder joints in decreasing order of frequency [2] . Radiosynovectomy or radiosynoviorthesis is an established technique involving intra-articular administration of radiopharmaceuticals labeled with high-energy beta-emitting radionuclides for the treatment of various joint pathologies including rheumatoid arthritis and other inflammatory arthropathies [3] . We present the first case of a young male with PSOC of the right knee with severe joint immobility and pain treated with radiosynovectomy prior to surgery, facilitating en bloc disease resection with adjunctive therapeutic benefit.
Case Report
A 25-year-old male patient presented with progressive swelling and pain around the right knee joint for the last 1.5 years. The history was negative for any previous trauma or other articular symptoms. There was large peri-articular swelling of the right knee with associated tenderness and restriction of joint mobility on examination. Evaluation with plain radiography revealed multiple irregular calcific deposits in the peri-articular soft tissues of the right knee (Fig. 1a) . Magnetic resonance imaging demonstrated diffuse synovial thickening (involving the periarticular bursal recesses) and associated moderate synovial effusion. Numerous hypointense focal areas were also noted in the synovium and bursal recesses suggesting a diagnosis of synovial chondromatosis. Synovial fluid evaluation was non-contributory. The patient was referred for the management of pain and swelling with a radiosynovectomy procedure. Three-phase 99m Tc-MDP skeletal scintigraphy of the knee region was performed as a prerequisite for radiosynovectomy. It revealed increased flow and peri-articular soft tissue pooling of the tracer suggesting active synovial inflammation in the right knee ( Fig. 2a-c) . Radiosynovectomy was performed by intra-articular injection of 555 MBq of 188 Re-tin colloid prepared in the in-house radiopharmacy. Synovial fluid was initially aspirated followed by instillation of the radiopharmaceutical into the joint with a saline flush to clear any residual activity in the same sitting Significant reduction (arrow and arrowheads) in the tracer distribution (all the phases) is noted in the follow-up three-phase scintigraphy at 6 months under strict aseptic conditions. The joint was briefly mobilized to ensure uniform distribution of the radiopharmaceutical within the synovium and then immobilized for 48 h using a knee splint to minimize extra-articular spread. Post-therapy scintigraphy at 1 h revealed adequate homogeneous intra-articular distribution of the radiopharmaceutical. Subsequently, the patient was followed up at 3-and 6-month intervals post-therapy with clinical examination demonstrating remarkable improvement in the form of complete resolution of pain, significant reduction in swelling and restoration of joint mobility. A three-phase skeletal scintigraphy performed at 6 months showed a significant reduction in the bulk and inflammatory activity (Fig. 2d-f , Table 1 ). The patient underwent surgical synovectomy in view of the residual swelling and limitation of mobility. The resected surgical specimen was hard with a nodular surface and showed variable-sized whitish nodules on cut sections. Histopathology revealed areas of loose myxomatous connective tissue with multiple lobular clusters of chondrocytes (forming hyaline loose bodies) on a background of dense hyalinization and calcification confirming the diagnosis of synovial chondromatosis. There was a noticeable finding of the substantial radiation-induced dense hyalinization in the pathological synovium, which facilitated the en bloc resection (Fig. 1b) . The subsequent radiograph revealed adequate removal of the involved synovium (Fig. 1c) . The patient is currently asymptomatic with complete resolution of pain and near complete restoration of joint mobility.
Discussion
The clinical presentation of PSOC often involves pain, swelling, stiffness and locking of the knee with reduced joint mobility, tenderness, palpable loose bodies and crepitus noted on physical examination. Secondary osteoarthritic changes in long-standing cases can result in severe disability [4] . The debate is still ongoing regarding the pathophysiology (synovial metaplasia vs. benign neoplasm), but recent cytogenetic studies have favored a benign neoplastic etiology [5] , although the rare transformation into synovial chondrosarcoma is also reported in the literature [6] . Milligram proposed three phases of disease progression: the early phase having an active intra-synovial disease without any loose bodies, the transitional phase with both active synovial disease and loose bodies, and the late stage with multiple loose bodies without any intrasynovial disease [7] . Surgery, either open or arthroscopic excision, is the treatment of choice. However, a high recurrence rate (of even up to ∼23%) is reported in the literature [8] .
Different radiopharmaceuticals in colloidal form are used for radiosynovectomy depending upon the joint size [3] . The radionuclide used in this index case was ( 188 Re). It has certain advantages such as having both beta and gamma radiation, around the clock availability of a 188 W/ 188 Re generator and ease of inhouse Re-188 tin colloid preparation, making it a very costeffective treatment option. It is often employed as an alternative therapy to early surgical synovectomy or as an adjunctive treatment to surgical procedures for optimal results [9] . To our knowledge, the utility of radiosynovectomy in the management of PSOC has not been reported so far in the existing literature. Complete removal of this disease is warranted in view of the possibility of post-surgical recurrence and the rare but plausible risk of malignant transformation. In the current patient, radiosynovectomy yielded dramatic improvement of symptoms, alleviating the need for analgesics, and also facilitated effortless intraoperative en bloc resection of the diseased synovium (unlike the conventional cumbersome piecemeal technique). The present case shows the potential role of radiosynovectomy in the management of synovial chondromatosis as an adjunctive therapeutic intervention prior to surgery.
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